Nasdaq

PCRX's Iovera Outperforms RFA Therapy in Pilot Study for Low Back Pain

Pacira BioSciences PCRX announced results from a pilot study evaluating the unique therapeutic approach of its iovera system compared to radiofrequency ablation (RFA) for chronic low back pain (CLBP).
Benzinga.com

Pacira BioSciences Secures FDA Approval For New iovera SmartTip to Manage Chronic Low Back Pain

On Tuesday, Pacira BioSciences, Inc. (NASDAQ:PCRX) received FDA clearance to market a new Smart Tip designed to access the medial branch nerves to manage chronic low back pain. The ioveraº system is a ...
Seeking Alpha

Pacira BioSciences Partners with The Invited Celebrity Classic – a PGA TOUR Champions Event – to Make iovera° The Official Non-Opioid Pain Management Partner

TAMPA, Fla. and IRVING, Texas, April 20, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions ...
Seeking Alpha

Centers for Medicare and Medicaid Services (CMS) Establishes Additional Payment for iovera in Outpatient Settings

-- Beginning January 1, 2025, providers can receive additional Medicare payment when they use EXPAREL or iovera° via product-specific reimbursement codes -- PARSIPPANY, N.J., Nov. 04, 2024 (GLOBE ...
WYFF

Brevard woman finds pain relief with targeted cold therapy

AND PAINS, BUT WE’RE LEERY OF USING MEDICATIONS LIKE OPIOIDS WITH THEIR POSSIBLE SIDE EFFECTS AND ISSUES. NOW, A NON-DRUG OPTION IS GIVING LONG TERM PAIN RELIEF. AND AS CAROL CLARKE FOUND, IT GAVE ONE ...